← Evidence map

ReviewFrontiers in pharmacology2022

New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022.

JingSi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36518658